BAY u9773--an LTC4 antagonist in the guinea pig trachea.

Abstract

Annals of the New York Academy of SciencesVolume 629, Issue 1 p. 402-404 BAY u9773—an LTC4 Antagonist in the Guinea Pig Trachea N. J. CUTHBERT, N. J. CUTHBERT Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorS. R. TUDHOPE, S. R. TUDHOPE Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorP. J. GARDINER, P. J. GARDINER Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorT. S. ABRAM, T. S. ABRAM Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorP. NORMAN, P. NORMAN Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorA. M. THOMPSON, A. M. THOMPSON Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorR. J. MAXEY, R. J. MAXEY Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorM. A. JENNINGS, M. A. JENNINGS Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this author N. J. CUTHBERT, N. J. CUTHBERT Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorS. R. TUDHOPE, S. R. TUDHOPE Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorP. J. GARDINER, P. J. GARDINER Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorT. S. ABRAM, T. S. ABRAM Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorP. NORMAN, P. NORMAN Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorA. M. THOMPSON, A. M. THOMPSON Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorR. J. MAXEY, R. J. MAXEY Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this authorM. A. JENNINGS, M. A. JENNINGS Bayer UK, Ltd. Pharmaceutical Business Group Research Department Stoke Court, Stoke Poges Slough SL2 4LY, EnglandSearch for more papers by this author First published: July 1991 https://doi.org/10.1111/j.1749-6632.1991.tb37997.xCitations: 19AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume629, Issue1Advances in the Understanding andTreatment of AsthmaJuly 1991Pages 402-404 RelatedInformation